侵袭性B细胞非霍奇金淋巴瘤治疗进展

Progress in the treatment of aggressive B-cell non-Hodgkin iymphoma

第23届欧洲血液学会（EHA）年会于2018年6月14日至17日在瑞典首都斯德哥尔摩召开。会议报告了3项嵌合抗原受体T细胞治疗弥漫大B细胞淋巴瘤的最新进展，以及多项免疫靶向药物的临床研究数据，均显示了令人鼓舞的疗效。现对侵袭性B细胞非霍奇金淋巴瘤的最新治疗进展进行简要介绍。

The 23rd Congress of the European Hematology Association （EHA） was held in Stockholm, Sweden from June 14-17, 2018. The latest analysis of three chimeric antigen receptor T-cell treatments for diffuse large B-cell lymphoma and clinical data from a number of immunotargeting drags were presented at this congress, all showing encouraging results. The recent progress of aggressive B-cell non-Hodgkin lymphoma is briefly introduced in this paper.